Renaissance Technologies LLC grew its stake in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) by 884.9% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 124,100 shares of the company's stock after…
